BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17851441)

  • 1. Synthesis and activity of a new series of (Z)-3-phenyl-2-benzoylpropenoic acid derivatives as aldose reductase inhibitors.
    Wang SJ; Yan JF; Hao D; Niu XW; Cheng MS
    Molecules; 2007 Apr; 12(4):885-95. PubMed ID: 17851441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
    Rastelli G; Ferrari AM; Costantino L; Gamberini MC
    Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted derivatives of indole acetic acid as aldose reductase inhibitors with antioxidant activity: structure-activity relationship.
    Juskova M; Majekova M; Demopoulos V; Stefek M
    Gen Physiol Biophys; 2011 Dec; 30(4):342-9. PubMed ID: 22131315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
    Celestina SK; Sundaram K; Ravi S
    Bioorg Chem; 2020 Apr; 97():103640. PubMed ID: 32086051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel synthesis of nitro-quinoxalinone derivatives as aldose reductase inhibitors.
    Hussain S; Parveen S; Qin X; Hao X; Zhang S; Chen X; Zhu C; Ma B
    Bioorg Med Chem Lett; 2014 May; 24(9):2086-9. PubMed ID: 24726808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of aldose reductase inhibition and docking studies of 6'-nitro and 6',6''-dinitrorosmarinic acids.
    Koukoulitsa C; Bailly F; Pegklidou K; Demopoulos VJ; Cotelle P
    Eur J Med Chem; 2010 Apr; 45(4):1663-6. PubMed ID: 20071057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of chiral 2H-chromene-N-imidazolo-amino acid conjugates as aldose reductase inhibitors.
    Gopinath G; Sankeshi V; Perugu S; Alaparthi MD; Bandaru S; Pasala VK; Chittineni PR; Krupadanam GLD; Sagurthi SR
    Eur J Med Chem; 2016 Nov; 124():750-762. PubMed ID: 27639366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of new potent inhibitor of aldose reductase from Ocimum basilicum.
    Bhatti HA; Tehseen Y; Maryam K; Uroos M; Siddiqui BS; Hameed A; Iqbal J
    Bioorg Chem; 2017 Dec; 75():62-70. PubMed ID: 28917123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.
    Metwally K; Pratsinis H; Kletsas D; Quattrini L; Coviello V; Motta C; El-Rashedy AA; Soliman ME
    Future Med Chem; 2017 Dec; 9(18):2147-2166. PubMed ID: 29098865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green fluorescent protein chromophore derivatives as a new class of aldose reductase inhibitors.
    Saito R; Hoshi M; Kato A; Ishikawa C; Komatsu T
    Eur J Med Chem; 2017 Jan; 125():965-974. PubMed ID: 27769036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
    Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
    Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
    Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
    Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein structure-based de novo design and synthesis of aldose reductase inhibitors.
    Iwata Y; Naito S; Itai A; Miyamoto S
    Drug Des Discov; 2001; 17(4):349-59. PubMed ID: 11765138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors.
    Hussain S; Parveen S; Hao X; Zhang S; Wang W; Qin X; Yang Y; Chen X; Zhu S; Zhu C; Ma B
    Eur J Med Chem; 2014 Jun; 80():383-92. PubMed ID: 24793885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
    Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
    Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrophenyl derivatives as aldose reductase inhibitors.
    Costantino L; Ferrari AM; Gamberini MC; Rastelli G
    Bioorg Med Chem; 2002 Dec; 10(12):3923-31. PubMed ID: 12413844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel aldose reductase inhibitors using a protein structure-based approach: 3D-database search followed by design and synthesis.
    Iwata Y; Arisawa M; Hamada R; Kita Y; Mizutani MY; Tomioka N; Itai A; Miyamoto S
    J Med Chem; 2001 May; 44(11):1718-28. PubMed ID: 11356107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold.
    Chen X; Yang Y; Ma B; Zhang S; He M; Gui D; Hussain S; Jing C; Zhu C; Yu Q; Liu Y
    Eur J Med Chem; 2011 May; 46(5):1536-44. PubMed ID: 21367494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Aldose Reductase Inhibitory Activity of Botryllazine A Derivatives.
    Saito R; Ishibashi K; Noumi M; Uno S; Higashi S; Goto M; Kuwahara S; Komatsu T
    Chem Pharm Bull (Tokyo); 2019; 67(6):556-565. PubMed ID: 31155561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pterin-7-carboxamides as a new class of aldose reductase inhibitors.
    Saito R; Suzuki S; Sasaki K
    Bioorg Med Chem Lett; 2016 Oct; 26(20):4870-4874. PubMed ID: 27666634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.